HCMV-encoded miR-UL112-3p promotes glioblastoma progression via tumour suppressor candidate 3

Area of Science:

• Oncology
• Virology
• Molecular Biology

Background:

• Glioblastoma (GBM) is a highly aggressive primary brain tumor.
• Human cytomegalovirus (HCMV)-encoded microRNAs (miRNAs) are implicated in disease pathogenesis, including GBM.

Purpose of the Study:

• To investigate the expression and function of HCMV-encoded miRNAs in GBM.
• To elucidate the role of miR-UL112-3p in GBM progression and identify its molecular targets.

Main Methods:

• Quantitative analysis of miR-UL112-3p expression in GBM tissues and cell lines.
• In vitro functional assays (proliferation, clone formation, migration, invasion) to assess miR-UL112-3p effects.
• Western blot and luciferase reporter assays to validate TUSC3 as a direct target of miR-UL112-3p.
• Investigation of the AKT signaling pathway.

Main Results:

• miR-UL112-3p expression is significantly upregulated in GBM and correlates with tumor stage and patient survival.
• Overexpression of miR-UL112-3p enhances GBM cell proliferation, migration, and invasion.
• Tumor suppressor candidate 3 (TUSC3) is a direct target of miR-UL112-3p and its expression is inversely correlated with miR-UL112-3p in GBM.
• Restoration of TUSC3 expression reverses miR-UL112-3p-induced GBM progression via the AKT pathway.

Conclusions:

• HCMV-encoded miR-UL112-3p acts as an oncogene in GBM by targeting TUSC3.
• miR-UL112-3p and its interaction with TUSC3 represent a potential therapeutic target for glioblastoma.